These findings elucidate a previously unrecognized biological significance and molecular mechanism of the MEX3A/circMPP6 complex underlying the CRC pathogenesis, providing novel prognostic markers and therapeutic targets for the CRC personalized treatment. This evidence concerns the gene MEX3A and colorectal carcinoma.